Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Renal Tubular Transport, Inborn Errors (D015499)
..Starting node
..expand
Pseudohypoaldosteronism (D011546)

       Child Nodes:
........expandPseudohypoaldosteronism, Type IIa (C564160)
........expandPseudohypoaldosteronism, Type IIb (C564161)
........expandPseudohypoaldosteronism, Type IIc (C564162)
........expandTunglang Savage Bellman syndrome (C536927)



 Sister Nodes: 
..expandAcidosis, Renal Tubular (D000141) Child11
..expandAzotemia, Familial (C566233)
..expandBartter Syndrome (D001477) Child8
..expandDent Disease (D057973) Child1
..expandDonnai-Barrow syndrome (C536390)
..expandFanconi Syndrome (D005198) Child3
..expandGitelman Syndrome (D053579) Child1
..expandGlycosuria, Renal (D006030) Child1
..expandHypomagnesemia 1, Intestinal (C566593)
..expandHypomagnesemia 2, renal (C537152)
..expandHypomagnesemia 4, Renal (C567127)
..expandHypomagnesemia 5, Renal, with Ocular Involvement (C565423)
..expandHypomagnesemia primary (C537153)
..expandHypomagnesemia, Hypertension, and Hypercholesterolemia, Mitochondrial (C564024)
..expandHypophosphatemia, Familial (D007015) Child11
..expandHypouricemia, Familial Renal, due to Tubular Hypersecretion (C564405)
..expandHypouricemia, Hypercalcinuria, and Decreased Bone Density (C565475)
..expandHypouricemia, Renal, 2 (C567426)
..expandIminoglycinuria (C536285)
..expandLiddle Syndrome (D056929)
..expandNephrolithiasis-Osteoporosis, Hypophosphatemic, 1 (C567363)
..expandNephrolithiasis-Osteoporosis, Hypophosphatemic, 2 (C567362)
..expandOculocerebrorenal Syndrome (D009800) Child1
..expandPseudohypoaldosteronism (D011546) Child4
..expandRenal Aminoacidurias (D000608) Child9
..expandRenal hypouricemia (C537757)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:9417
Name:Pseudohypoaldosteronism
Definition:A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION.
Alternative IDs:OMIM:145260|OMIM:177735|OMIM:264350|OMIM:603233|OMIM:612462
ParentIDs:MESH:D015499
TreeNumbers:C12.777.419.815.770 |C13.351.968.419.815.770 |C16.320.565.861.770 |C18.452.648.861.770
Synonyms:Familial Hyperpotassemia and Hypertension |Familial Hypertensive Hyperkalemia |Familial Hypertensive Hyperkalemias |Gordon Hyperkalemia Hypertension Syndrome |Gordon Hyperkalemia-Hypertension Syndrome |Hyperkalemia, Familial Hypertensive |Hyperkalemia-Hyperten
Slim Mappings:Genetic disease (inborn)|Metabolic disease|Urogenital disease (female)|Urogenital disease (male)
Reference: MedGen: D011546
MeSH: D011546
OMIM: 145260;

Genes: GNAS; GNAS-AS1; NR3C2; SCNN1A; SCNN1B; SCNN1G; STX16;
Phenotypes
1 HP:0000006Autosomal dominant inheritance
2 HP:0001995Hyperchloremic acidosis
3 HP:0002153Hyperkalemia
4 HP:0000822Hypertension
5 HP:0007215Periodic hyperkalemic paralysis
6 HP:0008242Pseudohypoaldosteronism
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_003590.4(CUL3):c.1376_1377+4del8452CUL3Pathogenic199469657RCV000128495; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368365225368370NM_003590.4:c.1376_1377+4delNC_000002.11:g.225368365_225368370delTTACCT-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1377+3A>G8452CUL3Pathogenic199469661RCV000128498; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368366225368366NM_003590.4:c.1377+3A>GNC_000002.11:g.225368366T>C-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1377+1G>C8452CUL3Pathogenic199469660RCV000128497; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368368225368368NM_003590.4:c.1377+1G>CNC_000002.11:g.225368368C>G-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1377dupG (p.Thr460Aspfs)8452CUL3Pathogenic199469659RCV000128496; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368369225368369NM_003590.4:c.1377dupGNP_003581.1:p.Thr460AspfsNC_000002.11:g.225368369dupC-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1376A>G (p.Lys459Arg)8452CUL3Pathogenic199469658RCV000128494; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368370225368370NM_003590.4:c.1376A>GNP_003581.1:p.Lys459ArgNC_000002.11:g.225368370T>C-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1238A>G (p.Asp413Gly)8452CUL3Pathogenic199469656RCV000128493; RCV000023258; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:15689008; MedGen:C3469606,OMIM:614496,ORPHA:3005302225368508225368508NM_003590.4:c.1238A>GNP_003581.1:p.Asp413GlyNC_000002.11:g.225368508T>COMIM Allelic Variant:603136.0007C3469606 614496 Pseudohypoaldosteronism type 2E; C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1236G>A (p.Leu412=)8452CUL3Pathogenic199469655RCV000128492; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368510225368510NM_003590.4:c.1236G>ANP_003581.1:p.Leu412=NC_000002.11:g.225368510C>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1207-1G>A8452CUL3Pathogenic199469654RCV000128487; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368540225368540NM_003590.4:c.1207-1G>ANC_000002.11:g.225368540C>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1207-3C>T8452CUL3Pathogenic199469653RCV000128490; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368542225368542NM_003590.4:c.1207-3C>TNC_000002.11:g.225368542G>A-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1207-5T>A8452CUL3Pathogenic199469652RCV000128491; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368544225368544NM_003590.4:c.1207-5T>ANC_000002.11:g.225368544A>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1207-12T>G8452CUL3Pathogenic199469651RCV000128486; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368551225368551NM_003590.4:c.1207-12T>GNC_000002.11:g.225368551A>C-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1207-26A>G8452CUL3Pathogenic199469650RCV000128488; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368565225368565NM_003590.4:c.1207-26A>GNC_000002.11:g.225368565T>C-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_003590.4(CUL3):c.1207-28T>G8452CUL3Pathogenic199469649RCV000128489; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890082225368567225368567NM_003590.4:c.1207-28T>GNC_000002.11:g.225368567A>C-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1723C>T (p.Arg575Trp)26249KLHL3Pathogenic199469646RCV000128520; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136961454136961454NM_017415.2:c.1723C>TNP_059111.2:p.Arg575TrpNC_000005.9:g.136961454G>A-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1670A>G (p.Tyr557Cys)26249KLHL3Pathogenic199469645RCV000128524; RCV000023478; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:15689008; MedGen:C3469605,OMIM:614495,ORPHA:3005255136961507136961507NM_017415.2:c.1670A>GNP_059111.2:p.Tyr557CysNC_000005.9:g.136961507T>COMIM Allelic Variant:605775.0007C3469605 614495 Pseudohypoaldosteronism type 2D; C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1583G>A (p.Arg528His)26249KLHL3Pathogenic199469636RCV000128519; RCV000023475; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:15689008; MedGen:C3469605,OMIM:614495,ORPHA:3005255136963994136963994NM_017415.2:c.1583G>ANP_059111.2:p.Arg528HisNC_000005.9:g.136963994C>TOMIM Allelic Variant:605775.0004C3469605 614495 Pseudohypoaldosteronism type 2D; C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1582C>T (p.Arg528Cys)26249KLHL3Pathogenic199469635RCV000128518; RCV000023479; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:15689008; MedGen:C3469605,OMIM:614495,ORPHA:3005255136963995136963995NM_017415.2:c.1582C>TNP_059111.2:p.Arg528CysNC_000005.9:g.136963995G>AOMIM Allelic Variant:605775.0008C3469605 614495 Pseudohypoaldosteronism type 2D; C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1501C>A (p.Pro501Thr)26249KLHL3Pathogenic199469634RCV000128511; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136964076136964076NM_017415.2:c.1501C>ANP_059111.2:p.Pro501ThrNC_000005.9:g.136964076G>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1480G>A (p.Ala494Thr)26249KLHL3Pathogenic199469633RCV000128503; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136964097136964097NM_017415.2:c.1480G>ANP_059111.2:p.Ala494ThrNC_000005.9:g.136964097C>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1410G>A (p.Trp470Ter)26249KLHL3Pathogenic199469644RCV000128499; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136969766136969766NM_017415.2:c.1410G>ANP_059111.2:p.Trp470TerNC_000005.9:g.136969766C>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1298G>A (p.Ser433Asn)26249KLHL3Pathogenic199469632RCV000128523; RCV000023480; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:15689008; MedGen:C3469605,OMIM:614495,ORPHA:3005255136973006136973006NM_017415.2:c.1298G>ANP_059111.2:p.Ser433AsnNC_000005.9:g.136973006C>TOMIM Allelic Variant:605775.0009C3469605 614495 Pseudohypoaldosteronism type 2D; C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1295G>A (p.Ser432Asn)26249KLHL3Pathogenic199469631RCV000128522; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136973009136973009NM_017415.2:c.1295G>ANP_059111.2:p.Ser432AsnNC_000005.9:g.136973009C>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1292G>A (p.Arg431Gln)26249KLHL3Pathogenic199469643RCV000128517; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136973012136973012NM_017415.2:c.1292G>ANP_059111.2:p.Arg431GlnNC_000005.9:g.136973012C>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1280T>C (p.Met427Thr)26249KLHL3Pathogenic199469642RCV000128509; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136973024136973024NM_017415.2:c.1280T>CNP_059111.2:p.Met427ThrNC_000005.9:g.136973024A>G-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1229C>T (p.Ser410Leu)26249KLHL3Pathogenic199469641RCV000128521; RCV000023474; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:15689008; MedGen:C3469605,OMIM:614495,ORPHA:3005255136973075136973075NM_017415.2:c.1229C>TNP_059111.2:p.Ser410LeuNC_000005.9:g.136973075G>AOMIM Allelic Variant:605775.0003C3469605 614495 Pseudohypoaldosteronism type 2D; C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1160T>C (p.Leu387Pro)26249KLHL3Pathogenic199469630RCV000128508; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136974701136974701NM_017415.2:c.1160T>CNP_059111.2:p.Leu387ProNC_000005.9:g.136974701A>G-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1151G>A (p.Arg384Gln)26249KLHL3Pathogenic199469629RCV000128516; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136974710136974710NM_017415.2:c.1151G>ANP_059111.2:p.Arg384GlnNC_000005.9:g.136974710C>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1019C>T (p.Ala340Val)26249KLHL3Pathogenic199469628RCV000128502; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136975551136975551NM_017415.2:c.1019C>TNP_059111.2:p.Ala340ValNC_000005.9:g.136975551G>A-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.1007G>T (p.Arg336Ile)26249KLHL3Pathogenic199469640RCV000128515; RCV000023477; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:15689008; MedGen:C3469605,OMIM:614495,ORPHA:3005255136975563136975563NM_017415.2:c.1007G>TNP_059111.2:p.Arg336IleNC_000005.9:g.136975563C>AOMIM Allelic Variant:605775.0006C3469605 614495 Pseudohypoaldosteronism type 2D; C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.965T>G (p.Phe322Cys)26249KLHL3Pathogenic199469639RCV000128507; RCV000023473; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:15689008; MedGen:C3469605,OMIM:614495,ORPHA:3005255136975605136975605NM_017415.2:c.965T>GNP_059111.2:p.Phe322CysNC_000005.9:g.136975605A>COMIM Allelic Variant:605775.0002C3469605 614495 Pseudohypoaldosteronism type 2D; C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.926A>G (p.Gln309Arg)26249KLHL3Pathogenic199469627RCV000128513; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136975644136975644NM_017415.2:c.926A>GNP_059111.2:p.Gln309ArgNC_000005.9:g.136975644T>C-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.753+1G>A26249KLHL3Pathogenic199469648RCV000128501; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136997603136997603NM_017415.2:c.753+1G>ANC_000005.9:g.136997603C>T-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.721delC (p.Leu241Phefs)26249KLHL3Pathogenic199469647RCV000128500; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085136997636136997636NM_017415.2:c.721delCNP_059111.2:p.Leu241PhefsNC_000005.9:g.136997636delG-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.718C>T (p.Arg240Ter)26249KLHL3Pathogenic199469638RCV000128514; RCV000023476; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:15689008; MedGen:C3469605,OMIM:614495,ORPHA:3005255136997639136997639NM_017415.2:c.718C>TNP_059111.2:p.Arg240TerNC_000005.9:g.136997639G>AOMIM Allelic Variant:605775.0005C3469605 614495 Pseudohypoaldosteronism type 2D; C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.491G>T (p.Cys164Phe)26249KLHL3Pathogenic199469626RCV000128505; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085137028009137028009NM_017415.2:c.491G>TNP_059111.2:p.Cys164PheNC_000005.9:g.137028009C>A-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.430C>T (p.Gln144Ter)26249KLHL3Pathogenic199469637RCV000128512; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085137028070137028070NM_017415.2:c.430C>TNP_059111.2:p.Gln144TerNC_000005.9:g.137028070G>A-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.254A>C (p.Glu85Ala)26249KLHL3Pathogenic199469625RCV000128506; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085137034085137034085NM_017415.2:c.254A>CNP_059111.2:p.Glu85AlaNC_000005.9:g.137034085T>G-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.232A>G (p.Met78Val)26249KLHL3Pathogenic199469624RCV000128510; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085137045448137045448NM_017415.2:c.232A>GNP_059111.2:p.Met78ValNC_000005.9:g.137045448T>C-C1449844 145260 Pseudohypoaldosteronism, type 2
NM_017415.2(KLHL3):c.230C>A (p.Ala77Glu)26249KLHL3Pathogenic199469623RCV000128504; NGene:7830,MedGen:C1449844,OMIM:145260,ORPHA:757,SNOMED CT:156890085137045450137045450NM_017415.2:c.230C>ANP_059111.2:p.Ala77GluNC_000005.9:g.137045450G>T-C1449844 145260 Pseudohypoaldosteronism, type 2